Jul. 27 at 6:15 PM
$MIST some facts to grind on-
-More than 454,000 hospitalizations with AFib as the primary diagnosis happen each year with over 158k deaths
- estimated 2.7 to 6.1 million people in the US are affected by AFIB
-estimated cost to healthcare at
$26 billion
-If Cardamyst can address symptoms and reduce the burden to health care, this will be in fact a default therapy to treat the symptoms and reduce ER visits.
- Come Dec and anticipted PDUFA approval, this will be most anticipated therapy on the market!
wont be surprised if it gets scooped up
$15+ by
$BMY
$OCGN $SMMT $DRUG
